Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » HIV

HIV

Mar 30, 2020

PLOS Studies on Anti-Viral Epigenetic Drugs, Liver Cancer Oncogene, Brazilian HIV Diversity

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.

Mar 27, 2020

New Method for Detecting Point Mutations Could Significantly Impact Low-Cost Diagnostics

Premium

The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.

Mar 12, 2020

Jury Rules in Favor of Hologic, Grifols in BioMérieux Patent Infringement Lawsuit

BioMérieux had alleged infringement of two of its patents associated with nucleotide sequences to detect HIV-1 subtypes. 

Mar 11, 2020

And Then for All

NIH Director Francis Collins describes at Forbes how the agency is working with the Bill & Melinda Gates Foundation to develop gene-based treatments for sickle cell disease and HIV for sub-Saharan Africa.

Feb 19, 2020

OraSure Technologies Q4 Revenues Down 1 Percent

The firm saw strong increases in international HIV sales of its OraQuick HIV Self-Test product in the quarter.

Jan 30, 2020

Roche Diagnostics Keeps Eyes Firmly on China

Premium

China remains a key strategic market for Roche, and it said that it has multiple assays for 2019-nCoV coronavirus for research-use only. 

Jan 29, 2020

Hologic Fiscal Q1 Diagnostics Revenues Rise 5 Percent

Within diagnostics, the firm posted molecular diagnostics revenues of $178.5 million, up 9 percent from $164.3 million in fiscal Q1 2019.

Dec 03, 2019

Co-Diagnostics Joint Venture Gets Clearance in India for Five MDx Tests

The clearance covers tests made by the firm's joint venture for manufacturing, CoSara Diagnostics, in its facility in Ranoli, India.

Nov 07, 2019

OraSure Strives for End-to-End Presence in Microbiome Market with Diversigen Buy

Premium

The firm is also targeting a new market for oral fluid-based tests for drugs of abuse, projecting future growth due to new federal regulations.

Nov 06, 2019

OraSure Q3 Revenues Fall 22 Percent; Firm Announces $12M All-Cash Buy of Diversigen

OraSure will purchase Houston-based Diversigen, a microbiome and metagenomics consulting, sequencing, and data analysis service provider.

Pages

The Scan

Another Paper Gone

Retraction Watch writes that a cancer researcher has had an eighth paper retracted.

Computational Biologist James Taylor Dies

Computational biologist James Taylor has died, according to Johns Hopkins University.

Ever Infected

The Centers for Disease Control and Prevention is starting to test people for SARS-CoV-2 antibodies, according to the New York Times.

PLOS Papers on Hepatocellular Carcinoma Immune Cells, Regulatory Prostate Cancer Risk SNPs, More

In PLOS this week: features of tumor-infiltrating immune cells, regulatory effects of SNPs associated with prostate cancer risk, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.